Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Insulin resistance promotes Parkinsons disease through aberrant expression of -synuclein, mitochondrial dysfunction, and deregulation of the polo-like kinase 2 signaling
Compound identity at a glance Name: Retatrutide INN: LY3437943 Class: Triple incretin receptor agonist Structure: 39-amino-acid synthetic peptide Dosing interval: Once weekly (research protocols) Developer: Eli Lilly For the full molecular reference (molecular formula, molecular weight, CAS number and the 39-amino-acid sequence) see the Retatrutide molecular profile
Ajanta Pharma has now brokered similar regional in-licensing deals for semaglutide, accelerating distribution across over 20 countries in the Middle East and Africa
The key is using GLP-1s as part of a comprehensive approach that includes good nutrition and strength training, not as a standalone solution
US$ 24.93
US$ 22.18
US$ 27.08
US$ 28.79
US$ 26.89
